IFNA2 and chronic myelogenous leukemia, BCR-ABL1 positive: Homozygous deletion of IFN-α/β has been reported in leukemias, such as chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL) [74–78], and may be associated with resistance to IFN-α [79].